r/Stocksyourknowledge

Most people who followed $CYDY remember March 30, 2021. The FDA publicly stated that CytoDyn's claims about leronlimab were "misleading and not supported by the data", no benefit was shown in COVID-19 treatment trials. The stock dropped 25%+ that day.

What happened afterward was a class action lawsuit covering investors who held $CYDY between March 27, 2020 and March 30, 2022.

A $500,000 settlement has been reached and terms are now submitted to the court for approval.

Who qualifies?

Anyone who held $CYDY during the class period and suffered losses from the alleged misrepresentations about leronlimab's effectiveness for HIV and COVID-19.

Can I still apply?

Yes, you can submit your application now and it will be processed once claims filing officially opens after court approval.

If you were damaged by this don't forget to check your eligibility. GL!

Over the last 36 months, Indian retail investors lost an aggregate of ₹1,81,383 Crore in the equity derivatives (F&O) segment.Official SEBI data highlights:• 93% of individual traders suffered net losses.• Average loss per retail trader was ~₹1.2 Lakhs — exceeding the annual discretionary savings for households earning under ₹5 LPA.• On top of trading losses, retail participants paid an estimated ₹50,000 Crore in friction costs (brokerages, STT, exchange fees).• Only 1% of traders made more than ₹1 Lakh in net profit after transaction costs.The Structural Reality:F&O is not an investment desk — it is a zero-sum game with massive friction costs. Every rupee won is taken from another trader, while the house takes a mandatory toll on every transaction.75 years ago, in Chapter 1 of The Intelligent Investor (1949), Benjamin Graham warned against this exact dynamic:"The individual investor should never confuse speculation with investment. Wall Street’s machinery is designed to profit from activity, while the investor’s fortune is made by inactivity and capital preservation."When you trade multiple options contracts a week, you aren't investing. You are the liquidity provider of last resort to institutional high-frequency desks.We spent the last few weeks animating this entire forensic breakdown into a 50-second documentary case study to visualize where this ₹1.81 Lakh Crore actually flowed:• YouTube: https://www.youtube.com/shorts/4tpAAn2qZQY• Instagram: https://www.instagram.com/reel/Dd1Uo4Wz7TZ/Open question for the community:With SEBI increasing index lot sizes and curtailing weekly expiries, do you think this structural bleed will stop, or will retail liquidity simply migrate to other speculative assets?